KMT2A and acute lymphoblastic leukemia: In this study we identified the camptothecin-derivative 7-Ethyl-10-hydroxycamptothecin (SN-38), and in particular its pro-drug irinotecan (Camptosar), as highly effective agents against MLL-rearranged ALL.